Research graph
References from Drugs, Devices, and the FDA: Part 1. Local targets link to admitted publications; unresolved targets remain external evidence.
Unresolved reference
External reference
The safety and efficacy of new drug approval
1985 · External reference
Unresolved reference
External reference
Unresolved reference
1983 · External reference
A calm look at the drug lag
1987 · External reference
Invisible monuments and the costs of pharmaceutical regulation: twenty-five years of drug lag debate
2003 · External reference
AIDs and the politics of drug lag
1989 · External reference
Fatal cholestatic jaundice in elderly patients taking benoxaprofen
10.1136/bmj.284.6326.1372 · 1982 · External reference
At Lilly, the side-effects of Oraflex
1982 · External reference
Balancing early market access to new drugs with the need for benefit; risk data: a mounting dilemma
10.1038/nrd2664 · 2008 · External reference
The cost of drug development: a systematic review
10.1016/j.healthpol.2010.12.002 · 2011 · External reference
Innovation in the pharmaceutical industry: new estimates of R&D costs
10.1016/j.jhealeco.2016.01.012 · 2016 · External reference
Trial watch: Phase II and submission failures 2007–2010
10.1038/nrd3375 · 2011 · External reference
Trial watch: Phase II failures 2008–2010
10.1038/nrd3439 · 2011 · External reference
Trial watch: Phase II and Phase III attrition rates 2011–2012
10.1038/nrd4090 · 2013 · External reference
The FDA approval process for medical devices
10.1136/neurintsurg-2012-010400 · 2013 · External reference
Unresolved reference
External reference
Unresolved reference
External reference
Unresolved reference
External reference
Unresolved reference
External reference
Unresolved reference
External reference
Unresolved reference
External reference
Unresolved reference
External reference
Unresolved reference
External reference
Initial human testing: the IND application and Phase I testing
2009 · External reference
Unresolved reference
External reference
Unresolved reference
External reference
Unresolved reference
External reference
Unresolved reference
External reference
Unresolved reference
External reference
The statistics of phase 0 trials
10.1002/sim.3840 · 2010 · External reference
Unresolved reference
External reference
Phase 0 clinical trials: conceptions and misconceptions
10.1097/ppo.0b013e318172d6f3 · 2008 · External reference
Unresolved reference
External reference
Unresolved reference
External reference
Learning from the TGN1412 trial
10.1136/bmj.38797.635012.47 · 2006 · External reference
TGN1412: from discovery to disaster
2010 · External reference
Unresolved reference
External reference
Unresolved reference
External reference
Unresolved reference
External reference
Unresolved reference
External reference
Unresolved reference
External reference
